Streetbeat News

Revenues

OPRX

OptimizeRx Corp. (OPRX) reaffirmed its FY2023 revenue and adjusted EBITDA estimates in the range of $68M-$70M and $3M-$4M, respectively, consistent with prior guidance. The company is finalizing its year-end financials, including the impact of its acquisition of Medicx Health and operational realignment. A significant update includes the adjustment of revenue recognition from a gross to a net basis for Medicx Health's channel partners, leading to a revised 2024 revenue guidance of at least $100M, while maintaining the adjusted EBITDA guidance of over $11M for 2024. The company plans to discuss these results in a conference call on March 28, 2024.

Portfolio Pulse from Happy Mohamed

March 11, 2024 | 8:35 pm

BODI

The Beachbody Company projects its Q1 revenue to be between $113M and $121M.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 8:29 pm

FTEK

Fuel Tech has secured $2.1M in air pollution control orders, including two from new European customers for SCR technology, and contracts from existing customers in the Caribbean and the US for FUEL CHEM equipment and SNCR system upgrades, respectively. Deliveries are scheduled between Q2 2024 and Q1 2025.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 8:26 pm

CPHC

Canterbury Park Holding (NASDAQ:CPHC) reported a Q4 EPS of $0.27, up 22.73% from $0.22 YoY. However, sales decreased by 4.51% to $12.53M from $13.12M YoY.

Portfolio Pulse from Happy Mohamed

March 11, 2024 | 8:25 pm

LFMD

LifeMD projects Q1 revenue to be between $42M-$43M, closely aligning with the $42.54M estimate. For FY24, the company anticipates over $200M in revenue, surpassing the $191.52M estimate and adjusting its prior forecast from $195M-$205M.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 8:25 pm

IRBT

iRobot Corp. (NASDAQ:IRBT) announced its Q1 2024 preliminary financial results, with EPS and revenue below estimates but reiterated its FY24 outlook. Q1 EPS is expected between $(2.13) and $(2.00), against an $(1.98) estimate, and revenue between $137M and $142M, below the $158.62M estimate. The company maintains its full-year 2024 EPS outlook of $(3.73) to $(3.30) versus a $(3.58) estimate, and revenue forecast of $825M to $865M, compared to an $837.71M estimate. iRobot expects a revenue decline in the first half of 2024 but anticipates a mid-single-digit percentage revenue improvement in the second half.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 8:19 pm

MYPS

PLAYSTUDIOS forecasts its FY24 net revenue to be between $315M and $325M, which is in line with the estimated $318.65M.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 8:18 pm

BWMN

Bowman Consulting Group projects its FY24 net service billing to be between $363M and $378M.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 8:08 pm

ORCL

Oracle anticipates recognizing 43% of its $80 billion Remaining Performance Obligations as revenue in the next four quarters. Its Gen2 Cloud Infrastructure business, which grew 53% in Q3, is expected to continue its hypergrowth phase.

Portfolio Pulse from Benzinga Newsdesk

March 11, 2024 | 8:07 pm

SAP

Analyst ratings for SAP (NYSE:SAP) have shown a mix of opinions over the last three months, with recent updates indicating a positive shift in sentiment. The average 12-month price target for SAP has been raised to $198.2, marking a 16.45% increase from the previous target. This adjustment reflects analysts' growing optimism about SAP's market performance, despite the company facing challenges in revenue growth, net margin, ROE, ROA, and debt management compared to industry averages.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 8:00 pm